Tenascin-C is induced with progressive pulmonary vascular disease in rats and is functionally related to increased smooth muscle cell proliferation

Circulation Research

Volumn 79, Issue 6, 1996, Pages 1131-1142

  Jones, Peter Lloyd ^a   Rabinovitch, Marlene ^b,c  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

apoptosis; cell proliferation; extracellular matrix; pulmonary hypertension; tenascin C

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; EPIDERMAL GROWTH FACTOR; TENASCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SMOOTH MUSCLE FIBER;

EID: 0029806822     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.79.6.1131     Document Type: Article

References (94)

1. Rabinovitch M. Elastase, remodeling of the extracellular matrix, and pulmonary hypertension. Sem Respir Crit Care Med. 1994;15:199-206.
2. Meyrick B, Clarke SW, Symons C, Woodgate DJ, Reid L. Primary pulmonary hypertension: a case report including electronmicroscopic study. Br J Dis Chest. 1974;68:11-20.
3. Rosenberg HC, Rabinovitch M. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol. 1988;255:H1484-H1491.
4. Gerrity RG, Naito HK, Richardson M, Schwartz CJ. Dietary induced atherogenesis in swine: morphology of the intima in prelesion stages. Am J Pathol. 1979;95:755-792.
5. Liptay MJ, Parks WC, Mecham RP, Roby J, Kaiser LR, Cooper JD, Botney MD. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest. 1993;91:588-594.
6. Todorovich-Hunter L, Dodo H, Ye C, McCready L, Keeley FW, Rabinovitch M. Increased pulmonary artery elastolytic activity in adult rats with monocrotaline-induced progressive hypertensive pulmonary vascular disease compared with infant rats with nonprogressive disease. Am Rev Respir Dis. 1992;146:213-223.
7. Thompson K, Rabinovitch M. Exogenous leukocyte and endogenous elastases can mediate mitogenic activity in pulmonary artery smooth muscle cells by release of extracellular matrix-bound basic fibroblast growth factor. J Cell Physiol. 1995;166:495-505.
8. Todorovich-Hunter L, Johnson DJ, Ranger P, Keeley FW, Rabinovitch M. Altered elastin and collagen synthesis associated with progressive pulmonary hypertension induced by monocrotaline: a biochemical and ultrastructural study. Lab Invest. 1988;58:184-195.
9. Prosser I, Stenmark K, Suthar M, Crouch E, Mecham R, Parks W. Regional heterogeneity of elastin and collagen gene expression in intralobar arteries in response to hypoxic pulmonary hypertension as demonstrated by in situ hybridization. Am J Pathol. 1989;135:1073-1088.
10. Botney MD, Kaiser LR, Cooper JD, Mecham RP, Parghi D, Roby J, Parks WC. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol. 1992;140:357-364.
11. Boudreau N, Turley E, Rabinovitch M. Fibronectin, hyaluronan and a hyaluronan binding protein contribute to increased ductus arteriosus smooth muscle cell migration. Dev Biol. 1991;143:235-247.
12. Clausell N, Molossi S, Sett S, Rabinovitch M. In vivo blockade of tumor necrosis factor-α in cholesterol-fed rabbits after cardiac transplant inhibits acute coronary artery neointimal formation. Circulation. 1994;89:2768-2779.
13. Molossi S, Elices M, Arrhenius T, Diaz R, Coulber C, Rabinovitch M. Blockade of very late antigen-4 integrin binding to fibronectin with connecting segment-1 peptide reduces accelerated coronary arteriopathy in rabbit cardiac allografts. J Clin Invest. 1995;95:2601-2610.
14. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol. 1993;5:869-876.
15. Chiquet M, Fambrough DM. Chick myotendinous antigen, II: a novel extracellular glycoprotein complex consisting of large disulfide-linked subunits. J Cell Biol. 1984;98:1937-1946.
16. Erickson HP, Taylor HC. Hexabrachion proteins in embryonic chicken tissues and human tumors. J Cell Biol. 1987;105:1387-1394.
17. Bartsch S, Bartsch U, Dorries U, Faissner A, Weller A, Ekblom P, Schachner M. Expression of tenascin in the developing and adult cerebellar cortex. J Neurosci. 1992;12:736-749.
18. Ekblom P, Aufderheide E. Stimulation of tenascin expression in mesenchyme by epithelial-mesenchymal interactions. Int J Dev Biol. 1989;33:71-79.
19. Mackie EJ, Halfter W, Liverani D. Induction of tenascin in healing wounds. J Cell Biol. 1988;107:2757-2767.
20. Whitby DJ, Ferguson MWJ. The extracellular matrix of lip wounds in fetal, neonatal and adult mice. Development. 1991;112:651-668.
21. Chiquet-Ehrismann R, Mackie EJ, Pearson CA, Sakakura T. Tenascin: an extracellular matrix protein involved in tissue interactions during fetal development and oncogenesis. Cell. 1986;47:131-139.
22. Koukoulis GK, Gould VE, Ghattacharyya A, Gould JE, Howeedy AA, Virtanen I. Tenascin in normal, reactive, hyperplastic, and neoplastic tissues: biologic and pathologic implications. Hum Pathol. 1991;22:636-643.
23. Canfield AE, Schor AM. Evidence that tenascin and thrombospondin-1 modulate sprouting of endothelial cells. J Cell Sci. 1995;108:797-809.
24. Tremble P, Chiquet-Ehrismann R, Werb Z. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts. Mol Biol Cell. 1994;5:439-453.
25. Jones PL, Boudreau N, Myers CA, Erickson HP, Bissell MJ. Tenascin-C inhibits extracellular matrix-dependent gene expression in mammary epithelial cells: localization of active regions using recombinant tenascin fragments. J Cell Sci. 1995;108:519-527.
26. Hedin U, Holm J, Hansson GK. Induction of tenascin with rat arterial injury: relationship to altered smooth muscle cells phenotype. Am J Pathol. 1991;139:649-656.
27. Sharifi BG, LaFleur DW, Pirola CJ, Forrester JS, Fagin JA. Angiotensin II regulates tenascin gene expression in vascular smooth muscle cells. J Biol Chem. 1992;267:23910-23915.
28. Mackie EJ, Scott-Burden T, Hahn AW, Kern F, Bernhardt J, Regenass JS, Weller A, Buhler FR. Expression of tenascin by vascular smooth muscle cells: alterations in hypertensive rats and stimulation by angiotensin II. Am J Pathol. 1992;141:377-388.
29. Strange R, Li F, Saurer S, Burkhardt A, Friis RR. Apoptotic cell death and tissue remodelling during mouse mammary gland involution. Development. 1992;115:49-58.
30. Boudreau N, Sympson CJ, Werb Z, Bissell MJ. Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science. 1995;267:891-893.
31. Boudreau N, Werb Z, Bissell MJ. Suppression of apoptosis by the extracellular matrix in mammary epithelium: relationship to growth inhibition. Mol Biol Cell. 1995;6:3a. Abstract.
32. Cho A, Courtman DW, Langue BL. Apoptosis (programmed cell death) in arteries of the neonatal lamb. Circ Res. 1995;76:168-175.
33. Bochaton-Piallat ML, Gabbiani F, Redard M, Desmoulière A, Gabbiani G. Apoptosis participates in cellularity regulation during rat aortic intimal thickening. Am J Pathol. 1995;146:1059-1064.
34. Geng Y-J, Libby P. Evidence for apoptosis in advanced human atheroma. Am J Pathol. 1995;147:251-266.
35. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol. 1995;147:267-277.
36. Bennett MR, Evan GI, Schwartz SM. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways. Circ Res. 1995;77:266-273.
37. Wren FE, Schor AM, Schor SL, Grant ME. Modulation of smooth muscle cell behaviour by platelet-derived factors and the extracellular matrix. J Cell Physiol. 1986;127:297-302.
38. Elsdale T, Bard J. Collagen substrata for studies on cell behavior. J Cell Biol. 1972-54:626-637.
39. Schwartz SM, Bennett MR. Death by any other name. Am J Pathol. 1995;147:229-234.
40. Chung CY, Murphy-Ullrich JE, Erickson HP. Mitogenesis, cell migration and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II. Mol Biol Cell. 1996;7:883-892.
41. End P, Panayotou G, Entwistle A, Waterfield MD, Chiquet M. Tenascin: a modulator of cell growth. Eur J Biochem. 1992;209:1041-1051.
42. Vollmer G, Siegal GP, Chiquet-Ehrismann R, Lightner VA, Arnholdt H, Knuppen R. Tenascin expression in the human endometrium and in endometrial adenocarcinomas. Lab Invest. 1990;62:725-730.
43. Gatchalian CL, Schachner M, Sanes JR. Fibroblasts that proliferate near denervated synaptic sites in skeletal muscle synthesize the adhesive molecules tenascin (J1), N-CAM, fibronectin, and a heparan sulfate proteoglycan. J Cell Biol. 1989;108:1873-1890.
44. Aufderheide E, Ekblom P. Tenascin during gut development: appearance in the mesenchyme, shift in molecular forms, and dependence on epithelial-mesenchymal interactions. J Cell Biol. 1988;107:2341-2349.
45. Lightner VA, Sakai LY, Hall RP. IgA-binding structures in dermatitis herpetiformis skin are independent of elaslic-microfibrillar bundles. J Invest Dermatol. 1991;96:88-92.
46. Schalkwijk J, Van Vlijmen I, Oosterling B, Perret C, Koopman R, Van den Born J, Mackie EJ. Tenascin expression in hyperproliferative skin diseases. Br J Dermatol. 1991;124:13-20.
47. Stamp GW. Tenascin distribution in basal cell carcinomas. J Pathol. 1989;159:225-229.
48. Kuhn C, Mason RJ. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am J Pathol. 1995;147:1759-1769.
49. Mackie EJ, Chiquet-Ehrismann R, Pearson CA, Inaguma Y, Taya K, Kawarada Y, Sakakura T. Tenascin is a stromal marker for epithelial malignancy in the mammary gland. Proc Natl Acad Sci U S A. 1987;84:4621-4625.
50. Howeedy AA, Virtanen I, Laitinen L, Gould NS, Koukoulis GK, Gould VE. Differential distribution of tenascin in the normal, hyperplastic, and the neoplastic breast. Lab Invest. 1990;63:798.
51. Crossin KL, Hoffman S, Grumet M, Thiery J-P, Edelman GM. Site-restricted expression of cytotactin during development of the chicken embryo. J Cell Biol. 1986;102:1917-1930.
52. Akhurst RJ, Lehnert SA, Faissner A, Duffie E. TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development. 1990;108:645-656.
53. Lightner VA, Gumkowski FD. Bigner DD, Erickson HP. Tenascin/hexabrachion in human skin: biochemical identification and localization by light and electron microscopy. J Cell Biol. 1989;108:2483-2493.
54. Rettig WJ, Erickson HP, Albino AP, Garin-Chesa P. Induction of human tenascin (neuronectin) by growth factors and cytokines: cell type-specific signals and signalling pathways. J Cell Sci. 1994;107:487-497.
55. Chen C, Ku DN. Kikerki D, Lumbsden AB. Tenascin: a potential role in human arteriovenous PTFE graft failure. J Surg Res. 1996;60:409-416.
56. Hahn AW, Kern F, Jonas U, John M, Buhler FR, Resink TJ. Functional aspects of vascular tenascin-C expression. J Vase Res. 1995;32:162-174.
57. Clausell N, Molossi S, Rabinovitch M. Increased interleukin-1β and fibronectin expression are early features of the development of the post-cardiac transplant coronary arteriopathy in piglets. Am J Pathol. 1993;142:1772-1786.
58. Clausell N, Coles J, Rabinovitch M. Coronary arteriopathy postcardiac transplant in a heterotopic piglet model: the role of matrix cytokine interaction. Transplant Proc. 1993;25:859-860.
59. Lonnemann G, Engler-Blum G, Muller GA, Koch KM, Dinarello CA. Cytokines in human renal interstitial fibrosis, II: intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int. 1995;47:845-854.
60. Voelkel NF, Tuder RM, Bridges J, Arend WP. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol. 1994;11:664-675.
61. Ilkiw R, Todorovich-Hunter L, Maruyama K, Shin J, Rabinovitch M. SC-39026, a serine elastase inhibitor, prevents muscularization of peripheral arteries, suggesting a mechanism of monocrotaline-induced pulmonary hypertension in rats. Circ Res. 1989;64:814-825.
62. Ye C, Rabinovitch M. Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol. 1991;261:H1255-H1267.
63. Shemie S, Rabinovitch M. The effect of alpha-1 antitrypsin inhibition of early elastase release on the pathophysiology of progressive pulmonary hypertension. Am Rev Respir Dis. 1993;147:A495. Abstract.
64. Tucker RP, Hammarback JA, Jenrath DA, Mackie EJ, Xu Y. Tenascin expression in the mouse: in situ localization and induction in vitro by bFGF. J Cell Sci. 1993;104:69-76.
65. Meiners S, Marone M, Rittenhouse JL, Geller HM. Regulation of astrocytic tenascin by basic fibroblast growth factor. Dev Biol. 1993;160:480-493.
66. Hinek A, Molossi S, Rabinovitch M. Functional interplay between interleukin-1 receptor and elastin binding protein controls fibronectin synthesis in coronary artery smooth muscle cells. Exp Cell Res. 1996;225:122-131.
67. Clark EB, Hu N. Hemodynamics of the developing cardiovascular system. Ann N Y Acad Sci. 1990;588:41-47.
68. Langille BL. Remodeling of developing and mature arteries: endothelium, smooth muscle, and matrix. J Cardiovasc Pharmacol. 1993;21:S11-S17.
69. Chiquet-Ehrismann R, Tannheimer N, Koch M, Brunner A, Spring J, Martin D, Baumgartner S, Chiquet M. Tenascin-C expression by fibroblasts is elevated in stressed collagen gels. J Cell Biol. 1994;127:2093-2101.
70. Jones PL, Rabinovitch M. Tenascin-C permits epidermal growth factor-dependent vascular smooth muscle cell proliferation via the αvβ3 integrin receptor. Circulation. 1995;92:8(suppl I): I-111. Abstract.
71. Chung CY, Erickson HP. Cell surface annexin II is a high affinity receptor for the alternatively spliced segment of tenascin-C. J Cell Biol. 1994;126:539-548.
72. Betz E, Fallier-Becker P, Wolburg-Buchholz K, Fotev Z. Proliferation of smooth muscle cells in the inner and outer layers of the tunica media of arteries: an in vitro study. J Cell Physiol. 1991;147:385-395.
73. Glukhova MA, Frid MG, Koteliansky VE. Phenotypic changes of human aortic smooth muscle cells during development and in the adult vessel. Am J Physiol. 1991;261:78-80.
74. Perronneau I, Gavoille A, Perronneau P, Dubray C, Capron L. Heterogeneity in migration of smooth muscle cells from normal and injured rat thoracic aorta in primary culture. Cardiovasc Res. 1995;29:38-43.
75. Wohrley JD, Frid MG, Moiseeva EP, Orton EC, Belknap JK, Stenmark KR. Hypoxia selectively induces proliferation in a specific subpopulation of smooth muscle cells in the bovine neonatal pulmonary arterial media. J Clin Invest. 1995;96:273-281.
76. Frid MG, Moiseeva EP, Stenmark KR. Multiple phenotypically distinct smooth muscle cell populations exist in the adult and developing bovine pulmonary arterial media in vivo. Circ Res. 1994;75:669-681.
77. Tucker, RP. The in situ localization of tenascin splice variants and thrombospondin 2 mRNA in the avian embryo. Development. 1993;117:347-358.
78. Weller A, Beck S, Ekblom P. Amino acid sequence of mouse tenascin and differential expression of two tenascin isoforms during embryogenesis. J Cell Biol. 1991;112:355-362.
79. Zhao Y, Young SL. TGF-beta regulates expression of tenascin alternative-splicing isoforms in fetal rat lung. Am J Pathol. 1995;268:L173-L180.
80. Borsi L, Carnemolla B, Nicolo G, Spina B, Tanara G, Zardi L. Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast. Int J Cancer. 1992;52:688-692.
81. Murphy-Ullrich JE, Lightner VA, Aukhil I, Yan YZ, Erickson HP, Hook M. Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin. J Cell Biol. 1991;115:1127-1136.
82. Young SL, Chang LY, Erickson HP. Tenascin-C in rat lung: distribution, ontogeny and role in branching morphogenesis. Dev Biol. 1994;161:615-625.
83. Wallace WA, Howie SE, Lamb D, Salter DM. Tenascin immunoreactivity in cryptogenic fibrosing alveolitis. J Pathol. 1995;175:415-420.
84. James TN. Normal and abnormal consequences of apoptosis in the human heart: from postnatal morphogenesis to paroxysmal arrhythmias. Circulation. 1994;90:556-573.
85. Meyrick B, Reid L. Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. Lab Invest. 1980;42:603-615.
86. Zhu L, Wigle D, Hinek A, Kobayashi J, Ye C, Zuker M, Dodo H, Keeley FW, Rabinovitch M. The endogenous vascular elastase that governs development and progression of monocrotaline-induced pulmonary hypertension in rats is a novel enzyme related to the serine proteinase adipsin. J Clin Invest. 1994;94:1163-1171.
87. Scott-Burden T, Resink TJ, Baur U, Burgin M, Buhler FR. Epidermal growth factor responsiveness in smooth muscle cells from hypertensive and normotensive rats. Hypertension. 1988;13:295-304.
88. + exchange and growth factors in pulmonary artery smooth muscle cell proliferation. Am J Respir Cell Mol Biol. 1996;14:139-145.
89. Juliano RL, Haskill S. Signal transduction from the extracellular matrix. J Cell Biol. 1993;120:577-585.
90. Lin Y-C, Grinnell F. Decreased level of PDGF-stimulated receptor autophosphorylation by fibroblasts in mechanically relaxed collagen matrices. J Cell Biol. 1993;122:663-672.
91. Roskelley CD, Desprez PY, Bissell MJ. Extracellular matrix-dependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sci U S A. 1994;91:12378-12382.
92. Lin CQ, Dempsey PJ, Coffey RJ, Bissell MJ. Extracellular matrix regulates whey acidic protein expression by suppression of TGF-alpha in mouse mammary epithelial cells: studies in culture and in transgenic mice. J Cell Biol. 1995;129:1115-1126.
93. Plopper GE, McNamee HP, Dike LE, Bojanowski K, Ingber DE. Convergence of integrin and growth factor receptor signaling pathways within the focal adhesion complex. Mol Biol Cell. 1995;6:1349-1365.
94. Jones PL, Rabinovitch M. Tenascin-C facilitates epidermal growth factor-dependent vascular smooth muscle cell proliferation through interactions with the αvβ3 integrin receptor. Mol Biol Cell. 1995;6:4a. Abstract.